https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-06-25 11:00:132025-06-23 20:31:10Safety and Efficacy of DCCR in Patients with Prader-Willi Syndrome who have Pre-Diabetes or Diabetes
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-06-25 09:00:162025-06-25 19:05:15United In Hope: International Prader-Willi Syndrome Conference, 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-05-15 21:00:242025-05-17 16:37:42The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A Cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in U.S. Claims
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-05-14 21:00:142025-05-17 16:36:27Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-05-14 21:00:092025-05-17 16:38:40The International Society for Pharmacoeconomics and Outcomes Research, 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-05-13 09:00:492025-05-17 16:38:11Long-Term Results for Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome: Developmental Behaviour Checklist 2 Response and Relationship to Hyperphagia Reductions
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-05-13 09:00:392025-05-17 16:37:20The impact of Prader-Willi syndrome (PWS) on caregivers and the healthcare system: a burden of illness study design
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-05-13 09:00:132025-06-25 19:05:44European Congress of Endocrinology (ECE) and the European Society for Paediatric Endocrinology (ESPE), 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-04-01 20:00:092025-08-04 12:37:15Capturing the Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A Real-World Analysis of United States Claims Data.
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-14 17:16:522025-05-17 17:43:24Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal is Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in PWS (Study C614)
